Back
Editas Medicine Stock Predictions
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
37
EDIT
Editas Medicine
Last Price:
5.75
Seasonality Move:
4.23%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereEditas Medicine Stock Forecast
- Over the next 52 weeks, Editas Medicine has on average historically fallen by 10.5% based on the past 8 years of stock performance.
- Editas Medicine has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Editas Medicine Stock Undervalued?
The current Editas Medicine [EDIT] share price is $5.62. The Score for EDIT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Editas Medicine Stock Go Up Next Year?
- Over the next 52 weeks, Editas Medicine has on average historically fallen by 10.5% based on the past 8 years of stock performance.
Editas Medicine Stock Rating
Sell
37
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine overpriced?
- Editas Medicine has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Editas Medicine Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
editasmedicine.com
52-Week Data
52-Week High:
11.91
52-Week Low:
5.11
Prediction Charts
Market Cap:
459.79M
Price in USD:
5.62
Volume:
1.34M
Beta:
2.18
Technical Analysis
SMA50:
7.32
SMA100:
8.08
SMA200:
8.25
52-Wk Change:
-28.59%
Stock Predictions
-
Is Editas Medicine stock public?
Yes, Editas Medicine is a publicly traded company. -
What is the Editas Medicine stock quote today?
The Editas Medicine stock price is 5.62 USD today. -
How to buy Editas Medicine stock online?
You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-15 | 6.25 | 6.08 | 6.29 | 5.98 |
| Apr-16 | 5.98 | 5.85 | 6.03 | 5.85 |
| Apr-17 | 5.89 | 5.62 | 5.93 | 5.60 |
| Apr-18 | 5.60 | 5.55 | 5.68 | 5.51 |
| Apr-19 | 5.52 | 5.50 | 5.68 | 5.29 |
| Apr-22 | 5.59 | 5.61 | 5.79 | 5.38 |
| Apr-23 | 5.66 | 5.46 | 5.92 | 5.46 |
| Apr-24 | 5.51 | 5.35 | 5.59 | 5.28 |
| Apr-25 | 5.27 | 5.22 | 5.27 | 5.11 |
| Apr-26 | 5.25 | 5.32 | 5.40 | 5.13 |
| Apr-29 | 5.38 | 5.37 | 5.55 | 5.30 |
| Apr-30 | 5.33 | 5.22 | 5.36 | 5.20 |
| May-1 | 5.21 | 5.46 | 5.67 | 5.21 |
| May-2 | 5.54 | 5.62 | 5.64 | 5.41 |
Editas Medicine Earnings
Editas Medicine Earnings Report: Per Share Editas Medicine Earnings Q1 Q2 Q3 and Q4 last year and next year.
Editas Medicine Forecast Revenue Growth
Editas Medicine Stock Analysis: Historical quarterly revenues per share for Editas Medicine and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.17 per share.
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.